Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The hyperfiltration theory: a paradigm shift in nephrology

B M Brenner1, E V Lawler, H S Mackenzie

  • 1Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Kidney International
|June 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Is a reduction in albuminuria associated with renal and cardiovascular protection? A post hoc analysis of the ALTITUDE trial.

Diabetes, obesity & metabolism·2015
Same author

Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial.

Diabetologia·2010
Same author

Dye lasers using tapered optical fibers.

Applied optics·2010
Same author

Renal risk scores: progress and prospects.

Kidney international·2008
Same author

Predicting initiation and progression of chronic kidney disease: Developing renal risk scores.

Kidney international·2006
Same author

Renal risk and renoprotection among ethnic groups with type 2 diabetic nephropathy: a post hoc analysis of RENAAL.

Kidney international·2006
Same journal

Beyond galactose deficiency: redefining pathogenic IgA in IgA nephropathy.

Kidney international·2026
Same journal

KDIGO Life Cycle of Guideline Development Series Part 6: Bridging the Gap between Guidelines and Clinical Practice: The KDIGO Approach to Global Implementation and Education in Nephrology.

Kidney international·2026
Same journal

KDIGO Life Cycle of Guideline Development Series Part 5: Guideline updates and a living model for the future.

Kidney international·2026
Same journal

Crystal-storing histiocytosis causing severe acute kidney injury.

Kidney international·2026
Same journal

Peritoneal dialysis in a patient with extensive burn scarring.

Kidney international·2026
Same journal

COPA syndrome unmasked by anti-neutrophil cytoplasmic antibody-positive immune-complex nephritis.

Kidney international·2026
See all related articles

Glomerular hypertension drives progressive kidney damage. Reducing it through diet or medication slows disease progression in experimental and human chronic kidney disease.

Area of Science:

  • Nephrology
  • Experimental Nephrology
  • Clinical Nephrology

Background:

  • Glomerular hypertension is implicated in progressive renal damage following various injuries.
  • This condition is observed in experimental models and human diseases like diabetes mellitus and remnant kidneys.

Purpose of the Study:

  • To review the role of glomerular hypertension in chronic renal disease progression.
  • To evaluate the efficacy of interventions targeting glomerular hypertension in slowing disease progression.

Main Methods:

  • Review of experimental studies on renal damage and glomerular hypertension.
  • Analysis of clinical studies and large multicenter trials on dietary protein restriction and antihypertensive therapy.

Main Results:

Related Experiment Videos

  • Experimental evidence links glomerular hypertension to progressive renal damage.
  • Dietary protein restriction and antihypertensive therapy mitigate glomerular hypertension and slow damage in models.
  • Similar beneficial effects are observed in human chronic kidney disease, including diabetes mellitus and remnant kidneys.

Conclusions:

  • Glomerular hypertension is a key mediator of progressive renal damage.
  • Interventions that reduce glomerular hypertension, such as dietary protein restriction and antihypertensive therapy, are effective in slowing chronic kidney disease progression in both experimental settings and human patients.